VILLA, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 3.027
AS - Asia 2.167
EU - Europa 1.950
SA - Sud America 348
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 57
OC - Oceania 13
Totale 7.667
Nazione #
US - Stati Uniti d'America 2.858
IT - Italia 1.008
SG - Singapore 625
VN - Vietnam 484
CN - Cina 428
BR - Brasile 269
HK - Hong Kong 223
RU - Federazione Russa 195
DE - Germania 158
CA - Canada 103
FR - Francia 97
IE - Irlanda 79
GB - Regno Unito 74
BD - Bangladesh 73
SE - Svezia 70
IN - India 67
KR - Corea 55
ID - Indonesia 50
FI - Finlandia 41
NL - Olanda 41
ES - Italia 39
CH - Svizzera 31
PL - Polonia 28
AR - Argentina 27
AT - Austria 27
TR - Turchia 24
JP - Giappone 23
MX - Messico 19
PH - Filippine 18
ZA - Sudafrica 18
IQ - Iraq 15
EC - Ecuador 14
PK - Pakistan 13
UA - Ucraina 13
LT - Lituania 12
SA - Arabia Saudita 12
MA - Marocco 11
VE - Venezuela 11
UZ - Uzbekistan 10
AU - Australia 8
CR - Costa Rica 8
KE - Kenya 8
PE - Perù 8
BE - Belgio 7
CL - Cile 7
GT - Guatemala 6
JM - Giamaica 6
TH - Thailandia 6
CO - Colombia 5
EG - Egitto 5
HN - Honduras 5
IR - Iran 5
MY - Malesia 5
PR - Porto Rico 5
RO - Romania 5
TT - Trinidad e Tobago 5
GR - Grecia 4
JO - Giordania 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
DK - Danimarca 3
MU - Mauritius 3
OM - Oman 3
PY - Paraguay 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AG - Antigua e Barbuda 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
IL - Israele 2
KZ - Kazakistan 2
MK - Macedonia 2
RS - Serbia 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
GP - Guadalupe 1
HR - Croazia 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 7.556
Città #
Ashburn 406
Milan 353
Singapore 345
San Jose 311
Hong Kong 207
Dallas 195
Ho Chi Minh City 145
Hanoi 139
Los Angeles 106
Hefei 100
Ann Arbor 97
Council Bluffs 96
New York 96
Frankfurt am Main 79
Dublin 76
Beijing 68
Santa Clara 53
Seoul 51
Chicago 50
Columbus 48
Rome 38
The Dalles 38
Toronto 38
Jakarta 37
Munich 35
Chandler 33
Phoenix 32
Boardman 30
Buffalo 30
São Paulo 29
Montreal 28
Staranzano 27
Desio 26
Lauterbourg 26
Moscow 25
Zurich 24
Seveso 22
Fairfield 20
Helsinki 20
London 20
Kent 19
Tokyo 19
Warsaw 18
Atlanta 17
Denver 17
Houston 17
Monza 17
Brooklyn 16
Da Nang 16
Turku 16
Carate Brianza 15
Chennai 15
Haiphong 15
Stockholm 15
Turin 15
Nuremberg 14
Orem 14
Lissone 13
Seattle 13
Shanghai 13
Genoa 12
Naples 12
Poplar 12
Vienna 12
Amsterdam 11
Boston 11
Johannesburg 11
Paris 11
Rio de Janeiro 11
Ha Long 10
Perugia 10
Tashkent 10
Figino 9
Philadelphia 9
Washington 9
Ankara 8
Biên Hòa 8
Can Tho 8
Lima 8
Manchester 8
Quezon City 8
Seregno 8
Sesto San Giovanni 8
The Bronx 8
Wilmington 8
Brescia 7
Brussels 7
Campinas 7
Cesano Maderno 7
Ithaca 7
Kingston 7
Newark 7
Pune 7
Quận Bình Thạnh 7
Quận Một 7
San Diego 7
Baghdad 6
Bari 6
Concord 6
Corsico 6
Totale 4.254
Nome #
Investigation of drug resistance and co-mutational landscape of ALK-positive tumors 512
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 461
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 444
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 405
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 390
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 377
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 355
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 333
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 331
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 330
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 323
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering 318
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 316
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 297
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 294
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 267
New advances in liquid biopsy technologies for anaplastic lymphoma kinase (Alk)—positive cancer 260
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 259
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 258
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 236
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 208
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 182
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 178
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models 146
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution 123
Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations 64
Totale 7.667
Categoria #
all - tutte 21.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202254 0 0 0 4 10 5 8 3 7 6 3 8
2022/2023221 20 34 17 17 8 15 1 9 20 33 22 25
2023/2024477 41 22 22 20 59 94 73 16 34 23 30 43
2024/20251.551 52 94 88 78 105 58 98 43 181 255 156 343
2025/20263.897 485 322 402 496 365 182 517 148 255 350 135 240
2026/20271.309 206 260 427 416 0 0 0 0 0 0 0 0
Totale 7.667